Illinois Municipal Retirement Fund grew its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 35.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,352 shares of the company’s stock after buying an additional 31,890 shares during the period. Illinois Municipal Retirement Fund owned 0.10% of Henry Schein worth $8,467,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Versant Capital Management Inc grew its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC boosted its position in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC boosted its position in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. City State Bank purchased a new position in shares of Henry Schein during the 4th quarter worth approximately $55,000. Finally, Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.
Wall Street Analysts Forecast Growth
HSIC has been the subject of a number of research analyst reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Barrington Research increased their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Eight investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.
Henry Schein Price Performance
Shares of HSIC opened at $75.82 on Wednesday. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The firm’s fifty day simple moving average is $74.25 and its 200-day simple moving average is $72.43. The firm has a market capitalization of $9.45 billion, a price-to-earnings ratio of 31.20, a PEG ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the business posted $0.66 earnings per share. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. Equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Profitably Trade Stocks at 52-Week Highs
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- How Investors Can Find the Best Cheap Dividend Stocks
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Which Wall Street Analysts are the Most Accurate?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.